Retrospective analysis of clinical outcome and quality of life in patients undergoing surgical or conservative treatment of intracerebral cavernous malformations

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00006020

Enrollment

300

Registered

2015-08-18

Start date

2014-04-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

D18.0 G40.0

Interventions

Group 1: Cerebral Cavernous Malformation Surgical Treatment Assessment of functional outcome (Rankin Score), Seizure outcome (ILAE score), quality of life (SF 36), CCM hemorrhage risk with MRI follow

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Cerebral cavernous Malformation Microsurgical Therapy Pre Post Operative MRI Complete Dataset

Exclusion criteria

Exclusion criteria: Not willing to participate

Design outcomes

Primary

Measure	Time frame
Functional outcome at 1 year follow-up (Rankin score, Glasgow outcome score) quality of life at 1 year follow-up (Short form 36) seizure outcome at 1 year follow-up (International league against epilepsy score)	—

Secondary

Measure	Time frame
Functional outcome at max follow-up (Rankin score, Glasgow outcome score) quality of life at max follow-up (Short form 36) seizure outcome max follow-up (International league against epilepsy score)	—

Countries

Germany

Contacts

Public ContactPhilipp Dammann

Universitätsklinikum EssenKlinik für Neurochirurgie

philipp.dammann@uk-essen.de00492017231201

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026